Myositis with immune checkpoint inhibitors in a real-world setting

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2020年 / 1794卷 / 1期
关键词：
D O I：
10.1007/s40278-020-75807-7
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：11 / 11
相关论文
共 50 条
  • [31] Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
    Tsai, Hong-Ming
    Han, Meng-Zhi
    Lin, Yih-Jyh
    Chang, Ting-Tsung
    Chen, Chiung-Yu
    Cheng, Pin-Nan
    Chuang, Chiao-Hsiung
    Wu, I-Chin
    Chen, Po-Jun
    Kang, Jui-Wen
    Chiu, Yen-Cheng
    Chiu, Hung-Chih
    Chien, Shih-Chieh
    Kuo, Hsin-Yu
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (07) : 1929 - 1937
  • [32] A real-world study of immune checkpoint inhibitors in advanced triple-negative breast cancer
    Zhao, Weihong
    Zhang, Zheng
    Zhang, Yadi
    Chen, Yimeng
    Zhu, Yimin
    Liu, Chuanling
    Shao, Jiakang
    Zhang, Li
    Liu, Mei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [33] Acute kidney injury in patients receiving immune checkpoint inhibitors: a retrospective real-world study
    Lumlertgul, Nuttha
    Vassallo, Pietro
    Tydeman, Florence
    Lewis, Natasha
    Hobill, Abigail
    Weerapolchai, Kittisak
    Nordin, Nurul Zaynah
    Seylanova, Nina
    Martin, Luke
    Cennamo, Armando
    Wang, Yanzhong
    Rigg, Anne
    Shaunak, Nisha
    Ostermann, Marlies
    EUROPEAN JOURNAL OF CANCER, 2023, 191
  • [34] Immune checkpoint inhibitors increase the risk of kidney transplant rejection: a real-world pharmacovigilance study
    Wu, Junyan
    Huang, Jianxiang
    Zhu, Jianhong
    He, Zhichao
    Chen, Mengting
    Gao, Siyuan
    Liang, Dan
    Yu, Xiaoxia
    Lu, Chengyu
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (03) : 231 - 235
  • [35] Real-world experience and outcomes of immune-checkpoint inhibitors (ICI) in hepatocellular carcinoma (HCC)
    Paul, Samuel
    Min, Eric
    Benson, Katherine K.
    Xu, Menglin
    Noonan, Anne M.
    Mittra, Arjun
    Malalur, Pannaga G.
    Roychowdhury, Sameek
    Jin, Ning
    Hays, John L.
    Elkhatib, Rifat T.
    Rahman, Shafia
    Miller, Eric David
    Pardo, Dayssy Alexandra Diaz
    Manne, Ashish
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [36] REAL-WORLD INCIDENCE AND IMPACT OF PNEUMONITIS IN LUNG CANCER PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
    Tiu, Bruce
    Zubiri, Leyre
    Iheke, James
    Pahalyants, Vartan
    Theodosakis, Nicholas
    Ugwu-Dike, Pearl
    Seo, Jayhyun
    Tang, Kimberly
    Sullivan, Ryan
    Mooradian, Meghan
    Semenov, Yevgeniy
    Reynolds, Kerry
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A841 - A841
  • [37] REAL-WORLD RESULTS OF REIMBURSED IMMUNE CHECKPOINT INHIBITORS IN TAIWAN'S HEALTH INSURANCE SYSTEM
    Chien, L. C.
    Ying, Li H.
    VALUE IN HEALTH, 2022, 25 (12) : S468 - S468
  • [38] Genomic correlates of response and resistance to immune checkpoint inhibitors (ICI) in patients with metastatic urothelial carcinoma (mUC) in a real-world setting.
    Pramod, Nikhil
    Makarov, Vladimir
    Dawsey, Scott
    Pavicic, Paul G.
    Patgunarajah, Ubenthira
    Nair, Monica
    Ornstein, Moshe Chaim
    Gilligan, Timothy D.
    Wee, Christopher Eing
    Nizam, Amanda
    Mian, Omar Y.
    Nguyen, Jane
    Diaz-Montero, C. Marcela
    Gupta, Shilpa
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 670 - 670
  • [39] Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
    Hong-Ming Tsai
    Meng-Zhi Han
    Yih-Jyh Lin
    Ting-Tsung Chang
    Chiung-Yu Chen
    Pin-Nan Cheng
    Chiao-Hsiung Chuang
    I-Chin Wu
    Po-Jun Chen
    Jui-Wen Kang
    Yen-Cheng Chiu
    Hung-Chih Chiu
    Shih-Chieh Chien
    Hsin-Yu Kuo
    Cancer Immunology, Immunotherapy, 2021, 70 : 1929 - 1937
  • [40] Real-World Evidence of Incidence and Outcomes of Aplastic Anemia Following Administration of Immune Checkpoint Inhibitors
    Dasari, Srilatha
    Tse, William
    Wang, Jiasheng
    BLOOD, 2022, 140
12345